載入...
Monoclonal Antibodies to Treat Multiple Myeloma: A Dream Come True
Immunotherapy is increasingly used in the treatment of multiple myeloma (MM). Monoclonal antibodies (mAbs) are safe and effective ways to elicit immunotherapeutic responses. In 2015, daratumumab has become the first mAb approved by the Food and Drug Administration for clinical use in MM and, in the...
Na minha lista:
| 發表在: | Int J Mol Sci |
|---|---|
| Main Authors: | , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
MDPI
2020
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7662679/ https://ncbi.nlm.nih.gov/pubmed/33139668 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ijms21218192 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|